Squarepoint’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-274,743
| Closed | -$2.4M | – | 3215 |
|
|
2025
Q1 | $2.4M | Sell |
274,743
-315,767
| -53% | -$2.76M | ﹤0.01% | 1080 |
|
|
2024
Q4 | $8.48M | Sell |
590,510
-121,729
| -17% | -$1.75M | 0.01% | 590 |
|
|
2024
Q3 | $16.1M | Buy |
712,239
+196,356
| +38% | +$4.43M | 0.03% | 353 |
|
|
2024
Q2 | $10M | Buy |
515,883
+5,720
| +1% | +$111K | 0.02% | 468 |
|
|
2024
Q1 | $19.1M | Buy |
510,163
+270,788
| +113% | +$10.2M | 0.03% | 302 |
|
|
2023
Q4 | $13.4M | Sell |
239,375
-215,744
| -47% | -$12.1M | 0.03% | 368 |
|
|
2023
Q3 | $18.8M | Buy |
455,119
+338,311
| +290% | +$14M | 0.05% | 258 |
|
|
2023
Q2 | $6.52M | Buy |
116,808
+109,519
| +1,503% | +$6.12M | 0.02% | 493 |
|
|
2023
Q1 | $407K | Sell |
7,289
-2,202
| -23% | -$123K | ﹤0.01% | 1552 |
|
|
2022
Q4 | $346K | Sell |
9,491
-33,556
| -78% | -$1.22M | ﹤0.01% | 1628 |
|
|
2022
Q3 | $1.23M | Buy |
+43,047
| New | +$1.23M | 0.01% | 979 |
|
|
2022
Q1 | – | Sell |
-4,175
| Closed | -$622K | – | 2841 |
|
|
2021
Q4 | $622K | Buy |
+4,175
| New | +$622K | ﹤0.01% | 1477 |
|
|
2021
Q1 | – | Sell |
-44,709
| Closed | -$6.33M | – | 3063 |
|
|
2020
Q4 | $6.33M | Buy |
44,709
+42,359
| +1,803% | +$6M | 0.05% | 318 |
|
|
2020
Q3 | $293K | Sell |
2,350
-944
| -29% | -$118K | ﹤0.01% | 1686 |
|
|
2020
Q2 | $294K | Buy |
+3,294
| New | +$294K | ﹤0.01% | 1576 |
|